[1]周幽心,孙婷,杨伟廉,等. 硼中子俘获治疗人脑胶质母细胞瘤的前景和困惑[J]. 中国工程科学,2012,8(3):82-84.Zhou Youxin, Sun Ting, Yang Weilian, et al. Boron neutron capture therapy for glioblastoma of prospects and confused[J]. Engineering Science, 2012, 8(3): 82-84(in Chinese).
[2]赵修良,金晓峰,程晓龙,等. 硼中子俘获治疗中血硼浓度的测量方法[J]. 科技导报,2014,32(17):71-75.Zhao Xiuliang, Jin Xiaofeng, Cheng Xiaolong, et al. Development of blood boron concentration measurement in boron neutron capture therapy[J]. Science &Technology Review, 2014, 32(17): 71-75(in Chinese).
[3]王晓易.七成以上肿瘤患者需要进行放疗[EB/OL].(2017-12-12)[2018-03-31]. http:∥news.163.com/10/1123/14/6M6ALESK00014JB6.html.
[4]Bilski P, Budzanowski M, Ochab E, et al. Dosimetry of BNCT beams with novel thermoluminescent detectors[J]. Radiation Protection Dosimetry, 2004,110 (1-4) :623-626.
[5]Bilski P, Golnik N, Olko P, et al. lmproved dosimetry for BNCT by activation foils,mndlfled thermoluminescent detectors and recombination chambers[J]. NUKLEONIKA, 2004, 49(2): 51-56.
[6]曹明富,应蓓蓓,徐人尔,等. 肿瘤坏死因子α和β对电离辐射诱导细胞凋亡的效应[J]. 实验生物学报,2002(3):198-204.Cao Mingfu, Ying Beibei, Xu Rener, et al. Effect of tumor necrosis factor α and β on apoptosis induced by ionizing radiation[J]. Acta Biologiae Experimentalis Sinica, 2002(3): 198-204(in Chinese).
[7]李洪凌. 自由基对肿瘤细胞辐射效应影响的实验研究[D]. 北京:中国疾病预防控制中心,2009:1-40.
[8]Ma Y, Kepp O, Ghiringhelli F, et al. Chemotherapy and radiotherapy: cryptic anticancer vaccines[J]. Seminars in Immunology, 2010, 22(3): 113-124.
[9]Formenti S C, Demaria S. Systemic effects of local radiotherapy[J]. Lancet Oncol, 2009, 10(7): 718-726.
[10]江海燕,储德林. 硼中子俘获治癌的技术进展及关键问题[J]. 物理通报,2014,04:114-116.Jiang Haiyan, Chu Delin. The progression and key issues on treatment for cancer by means of boron neutron capture therapy technology[J]. Physics Bulletin, 2014, 4: 114-116(in Chinese).
[11]Betti O O, C Munari, Rosler R. St: 311 ereotactic radiosurgery with the linear accelerator: treatment of arteriovenous malformations[J].Neurol Surgery,1989(24): 311.
[12]昌爱武. 三维适形放射治疗技术的应用分析[J]. 中外医学研究,2013(17):154-155.Chang Aiwu. Application analysis of three dimensional conformal radiation therapy[J]. Chinese and Foreign Medical Research, 2013(17): 154-155(in Chinese).
[13]席强,涂恒业. 肿瘤放射治疗物理技术新进展[J]. 河北北方学院学报(自然学科版),2013,29(1):114-117.Xi Qiang, Tu Hengye. New advances in physical techniques for radiotherapy of tumors[J]. Journal of Hebei North University (Natural Science Edition), 2013, 29(1): 114-117(in Chinese).
[14]邹海哲. 四维放射治疗技术4D-CT重建技术在肝癌精确放疗定位的应用效果分析[J]. 世界最新医学信息文摘(电子版),2016(95):38.Zou Haizhe. Application effect of 4D-CT reconstruction technique for accurate radiotherapy of liver cancer[J]. World’s Latest Medical Information Digest (Electronic Edition), 2016(95): 38(in Chinese).
[15]孙艳美,孙婧,程桂娥. 例高龄右桥小脑角区脑膜瘤患者质子放射治疗的护理[J]. 中国实用护理杂志,下旬版,2006,22(12):41-42.Sun Yanmei, Sun Jing, Cheng Gui’e. Nursing care of patients with meningioma in the right cerebellopontine angle area of elderly patients with proton radiotherapy[J]. Chinese Journal of Practical Nursing, 2006, 22(12): 41-42(in Chinese).
[16]谢俊祥. 质子/重离子放射治疗技术及应用[J]. 中国医疗器械信息,2017,23(1):1-4.Xie Junxiang. Proton/Heavy ion radiation therapy and its application[J]. China Medical Device Information, 2017, 23(1): 1-4(in Chinese).
[17]hong Yong, Zewen Song, Yongmao Zhou. Boron neutron capture therapy for malignant melanoma: first clinical case report in China[J]. Chinese Journal of Cancer Research, 2016, 28(6): 634-640.
[18]罗军益,何佳恒. 硼中子俘获疗法治疗肿瘤及相关技术研究进展[J]. 辐射防护通讯,2010,30(2):26-29.Luo Junyi , He Jiaheng. Application of BNCT to tumor therapy[J]. Radiation Protection Bulletin, 2010, 30(2): 26-29(in Chinese).
[19]张紫竹,金从军,刘凯,等. 中子俘获疗法临床应用国际进展[J]. 中国工程科学,2012,9(8):100-105.Zhang Zizhu, Jin Congjun, Liu Kai. Neutron capture therapy clinical development in the world[J]. Engineering Science, 2012, 9(8): 100-105(in Chinese).
[20]Cruickshank G S, Ngoga D, Detta A, et al. A cancer research UK pharma-cokinetic study of BPA-mannitol in patients with high grade glioma to optimise uptake parameters for clinical trials of BNCT[J]. Appl Radiat Isot, 2009, 67(7-8 Suppl): S31-S33.
[21]Kawabata S, Miyatake S, Nonoguchi N, et al. Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients[J]. Appl Radiat Isot, 2009, 67(7/8 suppl): S15-S18.
[22]Miyatake S, Kawabata S, Yokoyama K, et al. Survival benefit of Boron neutron capture therapy for recurrent malignant gliomas[J]. J Neurooncol, 2009, 91(2): 199-206.
[23]Wordenl F P, Moon J, Samlowski W, et al. A phase ll evaluation of a3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of head and neck[J]. Cancer, 2006: 319-327.
[24]Cumberlin R L. Clinical research in neutron capture therapy[J]. Int J Radiat Oncol Biol Phys, 2002, 54(4): 992-998.
[25]Coderre J A. Neutron capture therapy of the 9L gliosarcoma using the p-boronophenylalaanine fructose, lnt[J]. Radiation Oncology Biol, phys, 1994: 643.
[26]Menendez P R, Roth B M C, Pereira M D, et al. BNCT for skinmelanoma in extremities: updated Argentine clinical results[C]∥Zonta A, et al. A New Option Against Cancer: Proceedings of the 14th lntemational Congress on Neutron Capture Therapy. Florence, ltaly, 2010: 7-8.
[27]Sakurai Y, Tanaka H, Takata T, et al. Advances in boron neutron capture therapy (BNCT) at Kyoto University from reactor-based BNCT to accelerator-based BNCT[J]. Journal of the Korean Physical Society, 2015, 67(1): 76-81.
[28]张紫竹. 硼中子俘获疗法关键技术取得突破性进展[J]. 科技成果管理与研究,2017(2):13.Zhang Zizhu. Breakthrough progress in key technologies of boron neutron capture therapy[J]. Scientific and Technological Achievements Management and Research, 2017(2): 13(in Chinese).
[29]叶娟. 积跬步致千里——周永茂谈我国中子照射器首例病患的临床试治[J].中国核工业,2014,10(9):59-61.Ye Juan. Accumulate a thousand miles-Zhou Yongmao talks about the clinical trials of the first case of neutron irradiation in China[J]. China Nuclear Industry, 2014, 10(9): 59-61(in Chinese).
[30]李大庆. 神奇中子如何定向“引爆”癌细胞[EB/OL]. (2017-08-17)[2018-04-02]. http:∥www. cas.cn/cm/201708/t20170817_4611459.shtml.
[31]周永茂. 迈入新世纪的硼中子俘获疗法(BNCT)[J]. 中国工程科学,2012,9(8):4-13.Zhou Yongmao. The boron neutorn capture therapy (BNCT) status to go into the new era[J]. Engineering Science, 2012, 9(8): 4-13(in Chinese).
[32]高峰,苑娇梅. 硼中子俘获治疗药物的研究进展[J]. 中国新药杂志,2010,19(4):296-300.Gao Feng, Yuan Jiaomei. Advances in drugs used in boron neutron capture therapy[J]. Chinese Journal of New Drugs , 2010, 19(4): 296-300 (in Chinese).
[33]Yang W, Barth B F. Molecular targeting of the epidermal growth factor receptor for BNCT of brain gliomas[R]. Ohio, USA: The Ohio State Universitv, 2011.
[34]Nedunchezhian K, Aswath N, Thiruppathy M, et al. Boron neutron capture therapy-a literature review[J]. Journal of Clinical and Diagnostic Research , 2016, 10(12): 1-4.
[35]Aris, Zonta. BNCT: a new option against cancer, president’s address. Proc. 13th International Congress on NCT. Florence, 2008, 2(7): 5-6.
[36]Kawabata S, Miyatake S, Hiramatsu R, et al. Phase Ⅱ clinical study of boron neutron capture therapy combined with X-ray radiotherapy/temozolomide in patients with newly diagnosed glioblastoma multiforme-study design and current status report[J]. Appl Radiat Isot, 2011, 69: 1796-1799.
[37]Barth R F. Boron neutron capture therapy at the crossroads: challenges and opportunities[J]. Appl Radiat Isot, 2009 , 67: 3-6.
[38]Jianling Wang, Leifeng Chen, Jing Ye, et al. Carborane derivative conjugated with gold nanoclusters for targeted cancer cell imaging[J]. Radiation Oncology, 2017, 18(5): 1466-1472.
[39]Sumitani S,Oishi M ,Yaguchi T, et al. Pharmacokinetics of core polymerized, boron-conjugated micelles designed for boron neutron capture therapy for cancer[J]. Biomaterials, 2012, 33(13): 3568-3577.
[40]代从新,姚勇,王任直. 硼中子俘获疗法治疗脑胶质瘤及难治性垂体腺瘤的现状及展望[J]. 中国工程科学,2012,14(8):96-99.Dai Congxin, Yao Yong, Wang Renzhi. Boron neutron capture therapy of gliomas and refractory pituitary adenomas: current status and future prospects[J]. Engineering Science, 2012, 14(8): 96-99(in Chinese).
[41]Yang W, Barth R, Wu G, et al. Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomas[J]. Appl Radiat Isot, 2004, 61(5): 981-985.
[42]Yang W, Wu G, Barth R F, et al. Molecular targeting and treatment of composite EGFR and EGFRvⅢ-positive gliomas using boronated monoclonal antibodies[J]. Clin Cancer Res, 2008, 14(3): 883-891.
[43]Huang W C, Chen Y J, Hung M C. Implication of nuclear EGFR in the development of resistance to anticancer therapies[J]. Biomedicine 2011, 1: 2-10.
[44]Kaniowski D, Ebenryter-Olbi′ nska K, Sobczak M, et al. High boron-loaded DNA-oligomers as potential boron neutron capture therapy and antisense oligonucleotide dual-action anticancer agents[J]. Molecules, 2017, 22: 1393-1413.
[45]Hwang K C, Lai P D, Chiang C S, et al. Neutron capture nuclei-containing carbon nanoparticles for destruction of cancer cells[J]. Biomaterials, 2010, 31(32): 8419-8425.
[46]Thirumamagal B T, Zhao X B, Bandyopadhyaya A K, et al. Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT)[J]. Bioconjug Chem, 2006, 17(5): 1141-1150.
[47]Elnakat H, Ratnam M. Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy[J]. Adv Drug Deliv Rev, 2004, 56(8):1067-1084.
[48]Ross J F, Chaudhuri P K, Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant-tissures in-vivo and in established cell-lines-physiological and clinical implications[J]. Cancer, 1994, 73 (9): 2432-2443.
[49]Gabizon A, Horowitz A T, Goren D, et al. Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)grafted liposomes: in vitro studies[J]. Bioconjug Chem, 1999,10 (2) : 289-298.
[50]Barth R F, Coderre J A, Vicente M G, et al. Boron neutron capture therapy of cancer: current status and future prospects[J]. Clin Cancer Res, 2005, 11: 3987-4002.
[51]Liu X, Ma S, Yao Y, et al. Differential expression of folate receptor alpha in pituitary adenomas and its relationship to tumor behavior[J]. Neurosurgery, 2012, 70: 1274-1280.
[52]Pantarotto D, Singh R, McCarthy D, et al. Functionalized carbon nanotubes for plasmid DNA gene delivery[J]. Angew Chem Int Ed, 2004, 43(39): 5242-5246.
[53]Kam N W S, Liu Z, Dai H J. Carbon nanotubes as intracellular transporters for proteins and DNA: an investigation of the uptake mechanism and pathway[J]. Angew Chem Int Ed, 2006, 45 (4): 577-581.
[54]Liu Z, Cai W, He L, et al. In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice[J]. Nat Nanotech, 2007, 2(1): 47-52.
[55]Yinghuai Z, Peng A T, Carpenter K, et al. Substituted carborane-appended water-soluble single-wall carbon nanotubes: new approach to boron neutron capture therapy drug delivery[J]. J Am Chem Soc, 2005, 127(27): 9875-9880.
[56]Mortensen M W, Bjorkdahl O, Sorensen P O, et al. Functionalization and cellular uptake of boron carbide nanoparticles: the first step toward T cell-guided boron neutron capture therapy[J]. Bioconjug Chem, 2006, 17(2): 284-290.
[57]Hiramatsu R, Kawabata S, Miyatake S, et al. Application of a novel boronated porphyrin (H2OCP) as a dual sensitizer for both PDT and BNCT[J]. Lasers Surg Med, 2011, 43(1): 52-58.
[58]Gottumukkala V, Luguya R, Fronczek F R, et al. Synthesis and cellular studies of an octa-anionic 5, 10, 15, 20-tetra[3, 5-( nido-carboranylmethyl) phenyl] porphyrin (H(2) OCP) for application in BNCT[J]. Bioorg Med Chem, 2005, 13(5): 1633-1640.
[59]Vicente M G H, Sibrian-Vazquez M. Syntheses of boronated porphyrins and their application in BNCT[J]. World Scientific Publishers, 2010, 4: 191-248.
[60]Renner M W, Miura M, Easson M W, et al. Recent progress in the syntheses and biological evaluation of boronated porphyrins for boron neutron-capture therapy[J]. Anticancer Agents Med Chem, 2006, 6(2): 145-157.
[61]Stummer W, Novotny A, Stepp H, et al. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinicacid-inducedporphyrins: Aprospective study in 52 consecutive patients[J]. J Neurosurg, 2000,93(6): 1003-1013.
[62]Hao E, Sibrian-Vazquez M, Serem W, et al. Synthesis, aggregation and cellular investigations of porphyrin-cobaltacarborane conjugates[J]. Chemistry, 2007, 13(32): 9035-9042.
[63]Kobayashi N, Allen N, Clendenon N R, et al. Animprovedrat brain-tumor model[J]. J Neurosurg, 1980, 53(6): 808-815.
[64]Choi K Y, Saravanakumar G, Park J H, et al. Hyaluronic acid-based nanocarriers for intracellular targeting: Interfacial interactions with proteins in cancer[J]. Colloids Surf B Biointerfaces, 2012, 99: 82-94.
[65]Toole B P. Hyaluronan: from extracellular glue to pericellular cue[J]. Nat Rev Cancer, 2004 , 4: 528-539.
[66]Auvinen P, Tammi R, Parkkinen J, et al. Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival[J]. Am J Pathol, 2000, 156: 529-536.
[67]Setala L P, Tammi M I, Tammi R H, et al. Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate[J]. Br J Cancer, 1999, 79: 1133-1138.
[68]Demina T S, Akopova T A, Vladimirov L V, et al. The study of the interaction between chitosan and 2, 2-Bis (hydroxymethyl) propionic acid during solid-phase synthesis[J]. Polym Sci Ser B, 2011 , 53: 358-370.
[69]Van den Berg R, Peters J A, van Bekkum H. The structure and (local) stability constants of borate esters of mono- and di-saccharides as studied by 11B and 13C NMR spectroscopy[J]. Carbohyd Res,1994, 253: 1-12.
[70]罗全勇,朱瑞森. 硼中子俘获治疗[J]. 同位素,2004,17(3):174.Luo Quanyong, Zhu Ruisen. Boron neutron capture therapy[J]. Journal of Isotopes, 2004, 17(3): 174(in Chinese).
[71]Henriksson R, Capala J, Michanek A, et al. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase Ⅱ study evaluating a prolonged high-dose of boronophenylalanine (BPA)[J]. Radiother Oncol, 2008, 88: 183-191.
[72]Yongpeng Tong. A novel EGFR-TKI inhibitor (cAMP-H3BO3 complex) combined with thermal therapy is a promising strategy to improve lung cancer treatment outcomes[J]. Oncotarget. 2017, DOI: 10.18632/oncotarget.17628.
[73]Barth R F, Vicente M G, Harling O K, et al. Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer[J]. Radiant Oncol, 2012, 7: 146-166.
[74]曹勤剑,郑建国,刘立业. 硼中子俘获治疗(BNCT)及剂量测量方法[J]. 中国辐射卫生,2016(2):221-224.Cao Qinjian, Zheng Jianguo, Liu Liye. Boron neutron capture therapy (BNCT) and dose measurement methods[J]. Radiation Health in China, 2016(2): 221-224.
[75]Kono Y, Kurihara H, Kawamoto H, et al. Radiation absorbed dose estimates for 18F BPA PET[J]. Original Article, 2017, 58(9): 1094-1100.
[76]Hatanaka H, Nakagawa Y. Clinical results of lonb surviving brain tumor patients who underwent boron neutron capture therapy[J]. International Journal of Radiation Oncology Biology Physics, 1994, 28(5): 1061-1066.
[77]Tang Xiuhuan, Jiang Xinbiao, Want Peng, et al. Research on method of detecting microscopic distribution of boron in sub-cellular tissue[J]. Atomic Energy Science and Technology, 2008, 42(6): 81-87.
[78]Zhao Zhumin, Zhang Liang, Jiang Xinbiao, et al. Calculation of IHNI-1 reactor core's neutronics parameters[J]. Science & Technology Review,2012, 30(20): 48-51.
[79]Peng Dan, Lu Jin, Zou Shuyun, et al. Measurement of thermal neutron fluence rate of in-hospital neutron irradiator by ssntd[J]. Atomic Energy Science and Technology, 2013, 47(8): 1368-1370.
[80]王静娟. 一体化PET/MR在脑功能方面的研究进展[J]. 医学影像学杂志,2017,27(9):1798-1799.Wang Jingjuan. Progress of hybrid PET/MR in brain function study[J]. Journal of Medical Imaging,2017, 27(9): 1798-1799(in Chinese).
[81]彭猛. 硫中子俘获治疗中子源技术研究[D]. 兰州:兰州大学,2017:1-63.
[82]江新标,张文首,高集金,等. 低浓化医院中子照射器(IHNI-1)堆芯的物理方案设计[J]. 中国工程科学,2009,11(11):17-21.Jing Jinbiao, Zhang Wenshou, Gao Jijin, et al. Design of physical scheme for core of low concentration hospital neutron illuminator (IHNI-1)[J]. China Engineering Science, 2009, 11(11): 17-21(in Chinese).
[83]Dai Congxin, Cai Feng, Hwang Kuochu. Folate receptor-mediated boron-10 containing carbon nanoparticles as potential delivery vehicles for boron neutron capture therapy of nonfunctional pituitary adenomas[J]. Science China Life Sciences, 2013, 56(2): 163-173.
[84]刘勇,陈一璋,小野公二,等. 细胞水平的放疗:硼中子俘获疗法介绍[J]. 中华临床医师杂志,2011,5(22):6699-6702.Liu Yong, Chen Yizhang, Xiao Yegonger, et al. Cellular radiotherapy: introduction to boron neutron capture therapy[J]. Chinese Journal of Clinicians, 2011, 5(22): 6699-6702(in Chinese).
[85]Bortolussi S, Postuma I, Protti N, et al. Understanding the potentiality of accelerator based boron neutron capture therapy for osteosarcoma: dosimetry assessment based on the reported clinical experience[J]. Radiation Oncology, 2017, 10(12):86-91.
[86]刘政. 基于中子管中子发生器的硼中子俘获癌症治疗法的可行性研究[D]. 吉林:东北师范大学,2015:1-49.
[87]陈启亮. 中国5年内有望实现癌细胞“精准清除”[EB/OL]. (2017-08-11)[2018-04-02]. http:∥www.dzwww.com/xinwen/shehuixinwen/201708/t20170812_16281644.htm.
[88]Koltay E. Investigation on the excitation function of the nuclear reaction 9Be(d, n)10B, by artificially accelerated particles in the 0, 5-1, 6 MeV energy range[J]. Acta physical Academic Scientiarum Hungaricae, 1963, 16(2):93-100.
[89]Brune C R, Kavanagh R W. Total cross sections and thermonuclear reaction rates for 13C (d,n) and 14C (d,n)[J]. Physical Review C, 1992, 45(3): 1382-1388. |